Bladder Cancer | The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer

Featuring perspectives from Drs Arjun Balar, Siamak Daneshmand, Ashish M Kamat and Jonathan E Rosenberg on the following topics: Introduction (00:00) Immune checkpoint inhibitors for non-muscle-invasive urothelial bladder cancer (UBC) (4:17) Immune checkpoint inhibitors as neoadjuvant/adjuvant therapy for muscle-invasive UBC (25:42) Immune checkpoint inhibitors in advanced UBC (35:28) Current and future roles of recently FDA-approved novel therapies (51:02) CME information and select publications